Literature DB >> 24106314

Acupuncture modulates the neuro-endocrine-immune network.

S S Ding1, S H Hong, C Wang, Y Guo, Z K Wang, Y Xu.   

Abstract

As a nonspecific physical stimulation, the effect of acupuncture on diseases is produced by motivating the inherent regulatory system in the body, having the characteristics of whole regulation, dual directional regulation, etc. Modern scientific researches show that body's inherent regulatory system is neuro-endocrine-immune (NEI) network. Hence, we speculate that the regulatory effect of acupuncture may be produced through its regulation of NEI network. In this article, we reviewed the recent researches about acupuncture's effect on the NEI network, to find out the evidence of acupuncture adjusting NEI network and provide some evidences for revealing the mechanism of acupuncture.

Mesh:

Year:  2013        PMID: 24106314     DOI: 10.1093/qjmed/hct196

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  20 in total

Review 1.  Current Tracking on Effectiveness and Mechanisms of Acupuncture Therapy: A Literature Review of High-Quality Studies.

Authors:  Fu-Ming Yang; Lin Yao; Shen-Jun Wang; Yi Guo; Zhi-Fang Xu; Chien-Hung Zhang; Kuo Zhang; Yu-Xin Fang; Yang-Yang Liu
Journal:  Chin J Integr Med       Date:  2019-02-01       Impact factor: 1.978

2.  Blockade of the brachial plexus abolishes activation of specific brain regions by electroacupuncture at LI4: a functional MRI study.

Authors:  Weidong Gu; Wei Jiang; Jingwei He; Songbin Liu; Zhaoxin Wang
Journal:  Acupunct Med       Date:  2015-10-13       Impact factor: 2.267

3.  Applying Statistical and Complex Network Methods to Explore the Key Signaling Molecules of Acupuncture Regulating Neuroendocrine-Immune Network.

Authors:  Kuo Zhang; Xin-Meng Guo; Ya-Wen Yan; Yang-Yang Liu; Zhi-Fang Xu; Xue Zhao; Jiang Wang; Yi Guo; Kai Li; Sha-Sha Ding
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-29       Impact factor: 2.629

4.  Tiaolipiwei Acupuncture Reduces Albuminuria by Alleviating Podocyte Lesions in a Rat Model of Diabetic Nephropathy.

Authors:  Zhilong Zhang; Xinju Li; Liang Liu; Jiya Sun; Xu Wang; Zhiheng Zhao; Yuanqing Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-23       Impact factor: 2.629

5.  Decreased risk of pneumonia in stroke patients receiving acupuncture: A nationwide matched-pair retrospective cohort study.

Authors:  Chuen-Chau Chang; Ta-Liang Chen; Chao-Shun Lin; Chi-Li Chung; Chun-Chieh Yeh; Chaur-Jong Hu; Hsin-Long Lane; Chien-Chang Liao; Chun-Chuan Shih
Journal:  PLoS One       Date:  2018-05-21       Impact factor: 3.240

6.  Efficacy of acupuncture in improving the symptoms and the quality of life of patients with moderate or severe acne vulgaris: study protocol for a randomized controlled trial.

Authors:  Ruimin Jiao; Man Huang; Weina Zhang; Zhishun Liu
Journal:  Trials       Date:  2020-06-23       Impact factor: 2.279

7.  Clinical Experiences of Korean Medicine Treatment against Urinary Bladder Cancer in General Practice.

Authors:  Taeyeol Park; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-12       Impact factor: 2.629

8.  Autologous blood or autologous serum acupoint injection therapy for psoriasis vulgaris: A protocol for a systematic review and meta-analysis.

Authors:  Qiuyue Wang; Mao Li; Xingxin Hu; Qian Luo; Pingsheng Hao
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

9.  A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis.

Authors:  Jinhuan Zhang; Xingxian Huang; Yongfeng Liu; Yuhai He; Haibo Yu
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

10.  Moxibustion for treating cancer-related fatigue: A multicenter, assessor-blinded, randomized controlled clinical trial.

Authors:  Kyungsun Han; Mikyung Kim; Eun-Jung Kim; Yeon-Cheol Park; Ojin Kwon; Ae-Ran Kim; Hyo-Ju Park; Yang-Chun Park; Jung Hyo Cho; Joo-Hee Kim; Jun-Hwan Lee
Journal:  Cancer Med       Date:  2021-06-29       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.